Trial intelligence / Profile preview

Pharmacological properties of inhaled and oral terbutaline in healthy trained males

2014-002140-40Phase 4Completed

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of terbutaline in Healthy volunteer pharmacology (HVP) (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Urine concentration of terbutaline. Started Aug 2014; status: completed.

02

Drugs

terbutaline
03

Conditions

Healthy volunteer pharmacology (HVP)

Beyond the preview

Go deeper on 2014-002140-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002140-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call